- Home
- SYNX vs AIMD Comparison
SYNX vs AIMD Comparison
Compare SYNX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- AIMD
- Stock Information
- Founded
- SYNX 2005
- AIMD 1984
- Country
- SYNX Israel
- AIMD United States
- Employees
- SYNX N/A
- AIMD N/A
- Industry
- SYNX
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- AIMD Health Care
- Exchange
- SYNX Nasdaq
- AIMD Nasdaq
- Market Cap
- SYNX 9.7M
- AIMD 9.9M
- IPO Year
- SYNX 2024
- AIMD N/A
- Fundamental
- Price
- SYNX $1.85
- AIMD $0.55
- Analyst Decision
- SYNX
- AIMD
- Analyst Count
- SYNX 0
- AIMD 0
- Target Price
- SYNX N/A
- AIMD N/A
- AVG Volume (30 Days)
- SYNX 26.7K
- AIMD 197.4K
- Earning Date
- SYNX 05-21-2025
- AIMD 05-12-2025
- Dividend Yield
- SYNX N/A
- AIMD N/A
- EPS Growth
- SYNX N/A
- AIMD N/A
- EPS
- SYNX N/A
- AIMD N/A
- Revenue
- SYNX $9,893,000.00
- AIMD $20,729.00
- Revenue This Year
- SYNX $52.34
- AIMD N/A
- Revenue Next Year
- SYNX N/A
- AIMD N/A
- P/E Ratio
- SYNX N/A
- AIMD N/A
- Revenue Growth
- SYNX 18.05
- AIMD N/A
- 52 Week Low
- SYNX $1.71
- AIMD $0.40
- 52 Week High
- SYNX $6.49
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- SYNX 30.89
- AIMD 52.35
- Support Level
- SYNX $1.74
- AIMD $0.52
- Resistance Level
- SYNX $1.94
- AIMD $0.59
- Average True Range (ATR)
- SYNX 0.16
- AIMD 0.05
- MACD
- SYNX 0.02
- AIMD 0.00
- Stochastic Oscillator
- SYNX 21.12
- AIMD 50.70
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.